{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:31:22Z","timestamp":1777447882677,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202241"],"award-info":[{"award-number":["82202241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.crad.2026.107292","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:12:22Z","timestamp":1771431142000},"page":"107292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria"],"prefix":"10.1016","volume":"96","author":[{"given":"W.","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.crad.2026.107292_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.crad.2026.107292_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.crad.2026.107292_bib3","series-title":"Liver imaging reporting and data system","year":"2017"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.crad.2026.107292_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2017.11.007","article-title":"Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules","volume":"68","author":"Terzi","year":"2018","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.crad.2026.107292_bib6","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1007\/s00330-025-11495-3","article-title":"Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients","volume":"35","author":"Saborido","year":"2025","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.crad.2026.107292_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3348\/kjr.2024.0980","article-title":"Combination of CT\/MRI LI-RADS with second-line contrast-enhanced ultrasound using sulfur hexafluoride or perfluorobutane for diagnosing hepatocellular carcinoma in high-risk patients","volume":"26","author":"Li","year":"2025","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/HEP.0000000000000558","article-title":"Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe","volume":"79","author":"Lyshchik","year":"2024","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1016\/j.crad.2026.107292_bib9","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.crad.2026.107292_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.dld.2009.09.002","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal","volume":"42","author":"Trevisani","year":"2010","journal-title":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"4","key":"10.1016\/j.crad.2026.107292_bib11","first-page":"334","article-title":"Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis","volume":"98","author":"Techathuvanan","year":"2015","journal-title":"Journal of the Medical Association of Thailand = Chotmaihet thangphaet"},{"issue":"Suppl 2","key":"10.1016\/j.crad.2026.107292_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2036.17.s2.9.x","article-title":"Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre","volume":"17","author":"Grazi","year":"2003","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"10.1016\/j.crad.2026.107292_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2005.02.005","article-title":"The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma","volume":"42","author":"Bonilla Guerrero","year":"2005","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00261-021-03345-9","article-title":"The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B","volume":"47","author":"Yang","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.2019191086","article-title":"Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma","volume":"294","author":"Huang","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.crad.2026.107292_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/a-1168-6321","article-title":"Contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing hepatocellular carcinoma: diagnostic performance and interobserver agreement","volume":"43","author":"Zhou","year":"2022","journal-title":"Ultraschall Med"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1148\/radiol.2019190878","article-title":"Evaluation of Contrast-enhanced US LI-RADS version 2017: application on 2020 liver nodules in patients with hepatitis B infection","volume":"294","author":"Zheng","year":"2020","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.crad.2026.107292_bib18","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.ultrasmedbio.2021.08.007","article-title":"Impact of revision of the LR-M criteria on the diagnostic performance of contrast-enhanced ultrasound LI-RADS","volume":"47","author":"Ding","year":"2021","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.crad.2026.107292_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00330-019-06317-2","article-title":"Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017","volume":"30","author":"Li","year":"2020","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.crad.2026.107292_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11547-023-01614-9","article-title":"Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients","volume":"128","author":"Gong","year":"2023","journal-title":"Radiol Med"},{"issue":"4","key":"10.1016\/j.crad.2026.107292_bib21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00261-022-03428-1","article-title":"An assessment of liver lesions using a combination of CEUS LI-RADS and AFP","volume":"47","author":"Li","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"11","key":"10.1016\/j.crad.2026.107292_bib22","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ultrasmedbio.2024.08.003","article-title":"CEUS LI-RADS in combination with the serum biomarker-based ASAP model improves the diagnostic performance of HCC in high-risk patients","volume":"50","author":"Wen","year":"2024","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.crad.2026.107292_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.crad.2026.107292_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2214\/AJR.21.26837","article-title":"LR-M observations on contrast-enhanced ultrasound: detection of hepatocellular carcinoma using additional features in comparison with current LI-RADS Criteria","volume":"219","author":"Xian","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"46","key":"10.1016\/j.crad.2026.107292_bib25","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.3748\/wjg.v26.i46.7325","article-title":"Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Yang","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.crad.2026.107292_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11547-021-01417-w","article-title":"Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017","volume":"127","author":"Zeng","year":"2022","journal-title":"Radiol Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:36:05Z","timestamp":1777379765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":26,"alternative-id":["S0009926026000681"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107292","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) for hepatocellular carcinoma diagnosis in non-cirrhotic hepatitis B virus infection patients: incorporating alpha-fetoprotein or adjusting washout criteria","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107292"}}